Cargando…

Tailoring drug release rates in hydrogel-based therapeutic delivery applications using graphene oxide

Graphene oxide (GO) is increasingly used for controlling mass diffusion in hydrogel-based drug delivery applications. On the macro-scale, the density of GO in the hydrogel is a critical parameter for modulating drug release. Here, we investigate the diffusion of a peptide drug through a network of G...

Descripción completa

Detalles Bibliográficos
Autores principales: Puvirajesinghe, T. M., Zhi, Z. L., Craster, R. V., Guenneau, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832740/
https://www.ncbi.nlm.nih.gov/pubmed/29445040
http://dx.doi.org/10.1098/rsif.2017.0949
_version_ 1783303353617350656
author Puvirajesinghe, T. M.
Zhi, Z. L.
Craster, R. V.
Guenneau, S.
author_facet Puvirajesinghe, T. M.
Zhi, Z. L.
Craster, R. V.
Guenneau, S.
author_sort Puvirajesinghe, T. M.
collection PubMed
description Graphene oxide (GO) is increasingly used for controlling mass diffusion in hydrogel-based drug delivery applications. On the macro-scale, the density of GO in the hydrogel is a critical parameter for modulating drug release. Here, we investigate the diffusion of a peptide drug through a network of GO membranes and GO-embedded hydrogels, modelled as porous matrices resembling both laminated and ‘house of cards’ structures. Our experiments use a therapeutic peptide and show a tunable nonlinear dependence of the peptide concentration upon time. We establish models using numerical simulations with a diffusion equation accounting for the photo-thermal degradation of fluorophores and an effective percolation model to simulate the experimental data. The modelling yields an interpretation of the control of drug diffusion through GO membranes, which is extended to the diffusion of the peptide in GO-embedded agarose hydrogels. Varying the density of micron-sized GO flakes allows for fine control of the drug diffusion. We further show that both GO density and size influence the drug release rate. The ability to tune the density of hydrogel-like GO membranes to control drug release rates has exciting implications to offer guidelines for tailoring drug release rates in hydrogel-based therapeutic delivery applications.
format Online
Article
Text
id pubmed-5832740
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher The Royal Society
record_format MEDLINE/PubMed
spelling pubmed-58327402018-03-05 Tailoring drug release rates in hydrogel-based therapeutic delivery applications using graphene oxide Puvirajesinghe, T. M. Zhi, Z. L. Craster, R. V. Guenneau, S. J R Soc Interface Life Sciences–Physics interface Graphene oxide (GO) is increasingly used for controlling mass diffusion in hydrogel-based drug delivery applications. On the macro-scale, the density of GO in the hydrogel is a critical parameter for modulating drug release. Here, we investigate the diffusion of a peptide drug through a network of GO membranes and GO-embedded hydrogels, modelled as porous matrices resembling both laminated and ‘house of cards’ structures. Our experiments use a therapeutic peptide and show a tunable nonlinear dependence of the peptide concentration upon time. We establish models using numerical simulations with a diffusion equation accounting for the photo-thermal degradation of fluorophores and an effective percolation model to simulate the experimental data. The modelling yields an interpretation of the control of drug diffusion through GO membranes, which is extended to the diffusion of the peptide in GO-embedded agarose hydrogels. Varying the density of micron-sized GO flakes allows for fine control of the drug diffusion. We further show that both GO density and size influence the drug release rate. The ability to tune the density of hydrogel-like GO membranes to control drug release rates has exciting implications to offer guidelines for tailoring drug release rates in hydrogel-based therapeutic delivery applications. The Royal Society 2018-02 2018-02-14 /pmc/articles/PMC5832740/ /pubmed/29445040 http://dx.doi.org/10.1098/rsif.2017.0949 Text en © 2018 The Authors. http://creativecommons.org/licenses/by/4.0/ Published by the Royal Society under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/, which permits unrestricted use, provided the original author and source are credited.
spellingShingle Life Sciences–Physics interface
Puvirajesinghe, T. M.
Zhi, Z. L.
Craster, R. V.
Guenneau, S.
Tailoring drug release rates in hydrogel-based therapeutic delivery applications using graphene oxide
title Tailoring drug release rates in hydrogel-based therapeutic delivery applications using graphene oxide
title_full Tailoring drug release rates in hydrogel-based therapeutic delivery applications using graphene oxide
title_fullStr Tailoring drug release rates in hydrogel-based therapeutic delivery applications using graphene oxide
title_full_unstemmed Tailoring drug release rates in hydrogel-based therapeutic delivery applications using graphene oxide
title_short Tailoring drug release rates in hydrogel-based therapeutic delivery applications using graphene oxide
title_sort tailoring drug release rates in hydrogel-based therapeutic delivery applications using graphene oxide
topic Life Sciences–Physics interface
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832740/
https://www.ncbi.nlm.nih.gov/pubmed/29445040
http://dx.doi.org/10.1098/rsif.2017.0949
work_keys_str_mv AT puvirajesinghetm tailoringdrugreleaseratesinhydrogelbasedtherapeuticdeliveryapplicationsusinggrapheneoxide
AT zhizl tailoringdrugreleaseratesinhydrogelbasedtherapeuticdeliveryapplicationsusinggrapheneoxide
AT crasterrv tailoringdrugreleaseratesinhydrogelbasedtherapeuticdeliveryapplicationsusinggrapheneoxide
AT guenneaus tailoringdrugreleaseratesinhydrogelbasedtherapeuticdeliveryapplicationsusinggrapheneoxide